Skip to main
ISRG
ISRG logo

Intuitive Surgical (ISRG) Stock Forecast & Price Target

Intuitive Surgical (ISRG) Analyst Ratings

Based on 40 analyst ratings
Buy
Strong Buy 38%
Buy 33%
Hold 23%
Sell 3%
Strong Sell 5%

Bulls say

Intuitive Surgical's stock has experienced significant growth, with shares rising 80% since the beginning of 2024, significantly outperforming the S&P 500's 28% increase during the same period. The company has reported robust financial performance, posting revenues of $2.41 billion, representing a 25% year-over-year increase, alongside an 18% growth in da Vinci procedures. This positive trend is supported by expanding indications, increasing utilization of existing systems, and ongoing innovations, positioning Intuitive Surgical favorably within a large and rapidly growing robotic minimally invasive surgery market.

Bears say

Intuitive Surgical is facing a challenging outlook due to lower-than-expected gross margin guidance for FY '25, which falls below company estimates, compounded by a decline in adjusted bariatrics volumes and subdued procedure growth in China. The financial analyst notes that macroeconomic uncertainty is adversely impacting hospital capital budgets, leading to delays in robotic system purchases, alongside resistance to adopting robotic solutions in emerging markets and extended rollouts for new technology platforms. Additionally, the company's relative P/E premium has decreased, reflecting a market contraction and raising concerns about future profitability amid these operational difficulties.

Intuitive Surgical (ISRG) has been analyzed by 40 analysts, with a consensus rating of Buy. 38% of analysts recommend a Strong Buy, 33% recommend Buy, 23% suggest Holding, 3% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Intuitive Surgical and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Intuitive Surgical (ISRG) Forecast

Analysts have given Intuitive Surgical (ISRG) a Buy based on their latest research and market trends.

According to 40 analysts, Intuitive Surgical (ISRG) has a Buy consensus rating as of Jul 10, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $531.44, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $531.44, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Intuitive Surgical (ISRG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.